Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Infertility in Females01:28

Infertility in Females

Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of endometrial...
Infertility in Males01:23

Infertility in Males

Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
In Vitro Fertilization01:24

In Vitro Fertilization

In vitro fertilization (IVF) is a form of assisted reproductive technology where an egg is fertilized with sperm in a controlled laboratory environment before transferring the resulting embryo into the uterus. This process is designed to help individuals and couples experiencing difficulties conceiving.
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Piloting the Clinician Scholars Program: Structured Mentoring, Staff Support, and Dedicated Academic Time to Build Family Medicine Research Capacity.

Family medicine·2026
Same author

Protocol for academic-community collaboration in the Sweet Dreams study, a community-integrated study of time tradeoffs, sleep, and cardiometabolic health among minoritized women.

Sleep advances : a journal of the Sleep Research Society·2026
Same author

Do race and ethnicity modify the association between pre-pregnancy and prenatal stressful life events and adverse birth outcomes among a population-based sample of at-risk women?

American journal of obstetrics & gynecology MFM·2026
Same author

Taking a Community-Partnered Approach to Developing Culturally-Responsive Mental Health Screening Materials for African-Born Adults in the United States.

Behavioral sciences (Basel, Switzerland)·2026
Same author

Subfecundity, Infertility Treatment, and Child Neurodevelopment.

JAMA network open·2026
Same author

Voces Latinas: A Qualitative Study of Cultural Values and Sleep Health, Insights from Latina Community Health Workers.

Hispanic health care international : the official journal of the National Association of Hispanic Nurses·2026

Related Experiment Video

Updated: Jun 2, 2026

Collection of Human Follicular Fluid, Follicle Somatic Cells, and Immature Oocytes from Individuals Undergoing In Vitro Fertilization
06:40

Collection of Human Follicular Fluid, Follicle Somatic Cells, and Immature Oocytes from Individuals Undergoing In Vitro Fertilization

Published on: October 24, 2025

Infertility treatment in a population-based sample: 2004-2005.

Sara E Simonsen1, Laurie Baksh, Joseph B Stanford

  • 1Department of Family and Preventive Medicine, University of Utah, Salt Lake City, UT 84108, USA. Sara.Simonsen@utah.edu

Maternal and Child Health Journal
|May 12, 2011
PubMed
Summary

Approximately 10.5% of women giving birth reported using infertility treatments. Fertility enhancing drugs were the most common, followed by assisted reproductive technology like in vitro fertilization.

More Related Videos

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives
08:46

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives

Published on: September 16, 2021

Related Experiment Videos

Last Updated: Jun 2, 2026

Collection of Human Follicular Fluid, Follicle Somatic Cells, and Immature Oocytes from Individuals Undergoing In Vitro Fertilization
06:40

Collection of Human Follicular Fluid, Follicle Somatic Cells, and Immature Oocytes from Individuals Undergoing In Vitro Fertilization

Published on: October 24, 2025

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives
08:46

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives

Published on: September 16, 2021

Area of Science:

  • Reproductive Health
  • Public Health Surveillance

Background:

  • Infertility affects a significant portion of reproductive-aged individuals.
  • Understanding patterns of fertility treatment utilization is crucial for public health planning.
  • The Pregnancy Risk Assessment Monitoring System (PRAMS) offers a valuable dataset for this research.

Purpose of the Study:

  • To characterize women utilizing infertility treatments.
  • To identify the types of fertility treatments sought by women with a recent live birth.
  • To explore factors associated with infertility treatment use in a population-based sample.

Main Methods:

  • Analysis of cross-sectional data from the PRAMS survey in seven U.S. states.
  • Inclusion of women who had a live birth.
  • Logistic regression modeling to identify correlates of infertility treatment utilization.

Main Results:

  • 10.5% of women reported using infertility treatments.
  • Fertility enhancing drugs were the most frequently reported treatment (29%).
  • Assisted reproductive technology (including in vitro fertilization) and artificial insemination with fertility drugs were also common.

Conclusions:

  • PRAMS data provide insights into infertility treatment use among women post-childbirth in the U.S.
  • Further research is needed to understand infertility prevalence, treatment choice determinants, and long-term outcomes.